One vindication by procurement, one falsification by Eroom’s Law, and a nanobot deadline that even Kurzweil has pushed back.
Twenty-one years after Singularity Is Near, ten claims Kurzweil said were already true: what held up, what got overtaken, and the company whose path he rewrote.
Kurzweil called the targets on medicine but missed the projectiles: wastewater not serum, mRNA not RNAi, senolytics not nanobots.
Kurzweil predicted diamondoid organs by the 2030s. What shipped is peptide drugs, living cells, and a titanium impeller on a magnetic field.
Twelve 2005 predictions on cell therapy, gene therapy, anti-amyloid vaccines, and diamondoid nanobots scored against 2026 clinical trials, patent filings, and approvals.